PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6262064-8	1980	Theophylline (5 x 10(-3) and 10(-2) M) stimulated cAMP accumulation and 5 x 10(-3) M theophylline potentiated the response to secretin and VIP.	Theophylline	85-97	vasoactive intestinal peptide	Rattus norvegicus	139-142	
3009718-2	1986	Incubation of rat brain frontal cortex slices with secretin or the structurally related peptides peptide histidine leucine (PHI) or vasoactive intestinal polypeptide (VIP) in the presence of 10 mM theophylline resulted in a dose-dependent increase in the cyclic AMP levels.	Theophylline	197-209	vasoactive intestinal peptide	Rattus norvegicus	132-165	
6185668-8	1982	In the presence of theophylline in the medium, amylase secretion was increased by 53-246% with 10(-9) to 10(-6) M-glucagon and 111-158% with 10(-7) and 10(-6) M-VIP respectively.	Theophylline	19-31	vasoactive intestinal peptide	Rattus norvegicus	161-164	
6248407-9	1980	Theophylline (5 x 10(-3) and 10(-2) M) stimulated cAMP accumulation and 5 x 10(-3) M theophylline potentiated the response to secretin and VIP.	Theophylline	85-97	vasoactive intestinal peptide	Rattus norvegicus	139-142	
6253842-6	1980	Theophylline (5 mg/ml, intraluminally) enhanced the effect of intra-arterial infusion of VIP (2 x 10(-9) mol/min/kg) as to net water secretion and increase in mucosal cyclic AMP content.	Theophylline	0-12	vasoactive intestinal peptide	Rattus norvegicus	89-92	
204536-2	1978	The secretory response to VIP, measured as the decrease in net absorptive flow rate (microliters 30 min-1 mg-1 of dry weight), was maximal and equalled the responses to theophylline or dibutyryl cyclic AMP.	Theophylline	169-181	vasoactive intestinal peptide	Rattus norvegicus	26-29